Adjuvant Development for a Thermostable Respiratory Influenza Vaccine
$599,749N01FY2018AINIH
Universal Stabilization Technologies, San Diego CA
Investigators
Abstract
The project is to develop synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs and delta-inulin as adjuvants within the context an influenza vaccine.
View original record on NIH RePORTER →